人工全髋置换联合髋臼造盖治疗先天性髋关节脱位  

Artificial total hip arthroplasty and hip-self procedure in the treatment of congenital dislocation of hip

作　　者：刘燚[1,2] 严建军[1,2] 崔志明[1,2] 

机构地区：[1]南通大学第二附属医院 [2]南通市第一人民医院骨科,江苏省南通市226001

出　　处：《中国组织工程研究》2013年第30期5434-5439,共6页Chinese Journal of Tissue Engineering Research

摘　　要：背景:以往采用单纯的人工关节置换、截骨重建等治疗成人CrownⅣ型先天性髋关节脱位的效果都不是很满意。目的:探讨人工全髋置换联合髋臼造盖重建治疗成人CrownⅣ型先天性髋关节脱位的疗效。方法:回顾性分析采用人工全髋置换联合髋臼造盖重建治疗23例成人CrownⅣ型先天性髋关节脱位的患者,其中男2例,女21例,年龄20-35岁,平均(24.26±3.56)岁。重建治疗后按Harrris髋关节功能标准评定术后疗效并进行统计学分析。结果与结论:23例患者均获得随访,随访时间为12-60个月,平均(26.60±13.16)个月。采用SPSS19.0进行统计学比较后发现,手术前后髋关节功能Harrris评分差异有显著性意义(P<0.01)。人工全髋置换联合髋臼造盖能重建髋关节正常结构,缓解疼痛,增加髋关节稳定性,是治疗成人CrownⅣ型先天性髋关节脱位的理想方法。BACKGROUND：The effects of artificial joint replacement, osteotomy and reconstruction in the treatment of Crown Ⅳ-type congenital dislocation of hip in adult are not very satisfied. OBJECTIVE：To evaluate the effect of artificial total hip arthroplasty and hip-self procedure in the treatment of Crown Ⅳ-type congenital dislocation of hip in adult patients. METHODS：Twenty-three adult patients with Crown Ⅳ-type congenital dislocation of hip were treated with artificial total hip arthroplasty and hip-self procedure. There were 2 males and 21 females with an average age of （24.26±3.56） years ranging 20 to 35 years. The effect was evaluated according to the Harrris evaluation standard, and the statistical analysis was performed. RESULTS AND CONCLUSION：Al of the patients were fol owed-up for 12-60 months, averaged of （26.60±13.16） months. Statistical comparison with the SPSS 19.0 system showed there was significant difference of the Harrris scores between preoperation and postoperation period （P〈0.05）. The artificial total hip arthroplasty and hip-self procedure can be used to reconstruct the normal function of hip joint, relieve pain and increase the joint stability, which is considered as the best method for the treatment of Crown Ⅳ-type congenital dislocation of hip in adult.

关 键 词：骨关节植入物 人工假体 先天性髋脱位 全髋关节置换 成人CrownⅣ型 髋臼造盖重建 非骨水泥髋臼假体 

分 类 号：R318[医药卫生—生物医学工程]